Retrospective observational study to evaluate therapeutic efficacy of Herbometallic Ayur-vedic compounds in the management of patients with chronic kidney disease (CKD) with respect to improvement in renal functions
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- To evaluate the changes in parameter pf renal function in patient of CKD undergoing biologically derived herbometallic Ayurveda therapies.
研究概览
简要总结
Chronic Renal disease is such a condition for which the modern therapeutics presently has certain limitations related to therapeutic options.Therefore this status is creating unmet clinical needs in such patients. In India the prevalence of CKD was observed to be 17.2% with ~6% have CKD stage 3 or worse. World-wide there is a rising incidence of chronic kidney disease that is likely to pose major problems for both healthcare and the economy in future years.
In†Ayurveda†several patients with chronic kidney diseases take treatment. But there lacks a systematic studies to determine the various benefits expected by the patients and the spectrum of benefits received by them. The present study is a retrospective observational study to evaluate the changes in parameters of renal functions and to evaluate the benefits of “Ayurveda†therapies as clinically observed and experienced by patients with Chronic Renal Failure undergoing Ayurvedic herbometallic formulations containing biologically derived metals and minerals.
In present study we will review retrospective medical chart of CKD patients.In the process there is no riskas identity of subjects is not disclosed.However the investigators will ensure maintaining patients confidentiality by using only patients code in study documents.
Data of each patient with a follow-up of minimum 3 months up to two years will be used and it will be collected from the available 50 case papers and source documents of patients fulfilling the eligibility criteria. After wards patient’s blood parameters will be measured.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- All
入选标准
- •Primary diagnosis of Chronic Renal Failure with Serum creatinine >1.5 mg/dL Elevated Cystantin C level Patients taking or has taken Ayurved therapy for treatment of Chronic Renal Failure Patients taking or has taken Ayurved therapies for a minimum period of 3 months.
排除标准
- •Patients taking or has taken injection of erythropoietin.
结局指标
主要结局
To evaluate the changes in parameter pf renal function in patient of CKD undergoing biologically derived herbometallic Ayurveda therapies.
时间窗: Data of each patient for a follow up of minimum three months upto two years will be used.
次要结局
- To evaluates the benefits of "Ayurveda" therapies as clinically observed and experienced by patient with chronic renal failure undergoing these therapies.
